WBDE(SZ:002082) Zheng Quan Zhi Xing·2025-09-02 16:26Agreement Overview - The controlling shareholder, Wanbangde Group, and actual controllers Zhao Shouming and Zhuang Hui, along with their concerted actions, have signed a share transfer agreement with Wanlong Pharmaceutical [1] - The shares will be transferred at a price of 6.88 CNY per share, totaling a significant number of shares [1] Progress of the Agreement - On September 1, 2025, a supplementary agreement was signed, adjusting the share transfer price to 8.61 CNY per share based on the closing price of the previous trading day [2] - The total adjusted transfer price amounts to 516,600,000 CNY, with specific amounts allocated to each party involved in the transfer [2][3] Payment Terms - The payment timeline has been revised from three months to one month after the transfer of shares is completed [3] - Other terms of the original share transfer agreement remain unchanged [3] Future Considerations - The agreement is subject to compliance review by the Shenzhen Stock Exchange before the transfer can be finalized [4] - The company will continue to monitor the situation and ensure timely disclosure of relevant information [4]